Updated Jul 16, 2026
von Moltke Lisa has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $4K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-11-19 | MCRB | Seres Therapeutics, Inc. | S — Open-market sale [10b5-1] | 977 | $0.54 | $528 |
| 2024-11-19 | MCRB | Seres Therapeutics, Inc. | M — Option exercise [10b5-1] | 3.0K | — | |
| 2024-10-29 | MCRB | Seres Therapeutics, Inc. | S — Open-market sale [10b5-1] | 4.3K | $0.69 | $3K |
| 2024-10-29 | MCRB | Seres Therapeutics, Inc. | M — Option exercise [10b5-1] | 13.7K | $0.00 |
von Moltke Lisa is a corporate insider — currently tracked as See Remarks of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($4K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live von Moltke Lisa profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.